All GLG News Analyses Filed Under: Regulation & Administrative Law

In July 2007, the Australian Competition and Consumer Commission ( ACCC ) filed a world-first action alleging that Google Inc. and the Trading Post contravened the Trade Practices Act in 2005 when the classified business used the names of the car dealerships unrelated to the firm in paid, or sponsored,...

The fallacy of airport regulations is hindering development. There are perverse effects in all the economy.

See details of the proposal issued on October 1 by the Mexican antitrust commission to improve competitivenes in the Mexico City and four surrounding cities' airports, including the sale of government holdings. 

Audit Committees provide a safeguard against the excesses of the Board Board room politics, and can paralyse the audit committee

Protectionism, or "tit-for-tat" opening of markets is a discredited policy. Depriving some EU countries, not to mention the broader set of developing countries in Europe, of potential investment will not help their development. If "Third Party" investment is allowed, strong regulatory institutions must...

It seems that the UK authorities have made a choice for individual wind turbine equipment while other European countries privilege bigger collective wind turbines that use sophisticated technologies. Having said that, I would like to point out some open questions remain such: - Is any certification...

The Surface Transportation Board has proposed to change its methodology for calculating the railroad industry cost of capital.  The cost of capital is used for several regulatory purposes.  Lowering the cost of capital, as proposed by the agency, could increase the rate relief available to...

Post-Sarbanes Oxley, the skyrocketing audit costs have declined. Now is the time to leverage that investment into competitive advantage. In an ironic twist, the push-back from CEOs and Chambers of Commerce to roll back SOX will deliver profits to the profit-minded CEOs' bottom-line.

On its fifth anniversary, the Sarbanes_Oxley corporate reform law is being closely examined.  However, its longest-lasting, most powerful repercussions may be felt in the boardroom.

Greater resources for FDA will likely create more reporting requirements for pharmaceutical companies. FDA  will have greater authority to require post-marketing safety studies and to impose timetables for completing these studies. FDA's data may ultimately be fertile ground for class action...